Acutus Medical, Inc.

Good day and welcome to the ACUTUS Medical Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. As a reminder, this call may be recorded. I would like to turn the call over to Caroline Corner, IR.

You may begin. Thank you, Operator.

Welcome to ACUTUS's Second Quarter 2022 Earnings Call. Joining me on today's call is David Roman, Chief Executive Officer and Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. Factors that may cause results to differ from these forward-looking statements are discussed under the forward-looking statement section in the press release attached as an exhibit to Acutis' Form 8-K filed with the SEC today. They're also discussed in more detail under the risk factor section in ACUTUS's most recent filings with the SEC, including the risk factors described in ACUTUS's form 10-K. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. ACUTUS undertakes no obligation to update these statements except as required by applicable law. ACUTUS's press release for second quarter 2022 results is also available on the ACUTUS website, www.acutusmedical.com, under the Investors section, and includes additional details about ACUTUS's financial results. The ACUTUS website also has ACUTUS SEC filings, which you're encouraged to review. A recording of today's call will be available on the ACUTUS website by 5 p.m. Pacific time. Now I'd like to turn the call over to David.